UK experience with TACE
– Requirement for more refined selection of patients for TACE
Development of the Hepatic Arterial Prognosis score(HAP)
UK experience with sorafenib
Can we select patients more appropriately for TACE or systemic therapy?
Construction and validation of a TACE prognostic score